Compare IDEXX Laboratories, Inc. (IDXX) vs S&P Global Inc (SPGI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs S&P Global Inc — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while S&P Global Inc trades at $407.82 (market cap $118.72B). The key difference: S&P Global Inc is far larger — about 2.9× IDEXX Laboratories, Inc.'s market cap, and S&P Global Inc pays a 0.96% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and S&P Global Inc for 123 Days on average.
| IDXX | SPGI | |
|---|---|---|
Market Cap | $40.43B | $118.72B |
Volume | 692,164 | 1,647,917 |
Sector | Health | Financials |
52-Week High | $766.68 | $517.92 |
52-Week Low | $504.70 | $370.42 |
Typical Hold Time | 46 Days | 123 Days |
Enterprise Value | $41.32B | $130.21B |
Dividend Yield | — | 0.96% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
S&P Global (SPGI) trades at $402.73, up 1.91% with strong analyst support (85.7% buy ratings) and a $509.50 consensus price target. The stock shows solid fundamentals with 30.54% net margins and consistent revenue growth from $14.2B to $15.3B. Recent technical indicators show bearish momentum despite beating earnings expectations in two of the last three quarters. The company continues expanding through strategic acquisitions like OpenZeppelin and new product launches in digital asset risk assessment.
SPGI presents a compelling growth story with expanding margins and strategic positioning in financial data services. Key risks include market sensitivity to economic cycles and integration challenges from recent acquisitions. With strong cash flow generation and a dominant market position, the stock offers upside potential despite near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About S&P Global Inc
S&P Global provides data and benchmarks to capital and commodity market participants. In 2021 and excluding IHS Markit, S&P Ratings was over 45% of the firm's revenue and over 55% of the firm's operating income. S&P Ratings is the largest credit rating agency in the world. The firm's other segments include Market Intelligence, Indices, and Platts. Market Intelligence provides desktop tools and other data solutions to investment banks, corporations, and other entities. Indices provides benchmarks for financial markets and is monetized through subscriptions, asset-based fees, and transaction-based royalties. Platts provides benchmarks to commodity markets, principally petroleum.
Read more on SPGI →
